SEC Form 4 · accession 0001571049-15-003758
DR. TATTOFF, INC. · (NONE)
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gene E Burleson
Director
Period of report
Mar 10, 2015
Accepted (ET)
May 7, 2015 · 12:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001294157
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 10, 2015 | J | 361,822 | $0.00 | A | 1,152,468 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantsF1 | $0.75 | Mar 10, 2015 | J | 312,500 | D | — | — | Common Stock | 312,500 | 0 | D |
| WarrantsF1 | $0.60 | Mar 10, 2015 | J | 553,594 | D | — | — | Common Stock | 553,594 | 0 | D |
| Warrants | $0.78 | Mar 10, 2015 | J | 38,462 | D | Dec 31, 2013 | May 1, 2016 | Common Stock | 38,462 | 0 | D |
Explanation of responses
- F1Various
Remarks
The warrants were exchanged for the common stock at a ratio of 2.5 warrants for 1 share of stock. No cash was exchanged.